Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland ; volume:7 ; number:3 ; day:3 ; month:4 ; year:2023 ; pages:443-454 ; date:5.2023
PharmacoEconomics - open ; 7, Heft 3 (3.4.2023), 443-454, 5.2023
- Creator
-
Dymond, Amy
Green, Will
Edwards, Mary
Pont, Maria Angeles Lopez
Gupta, Girish
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s41669-023-00410-5
- URN
-
urn:nbn:de:101:1-2023090708553680043110
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dymond, Amy
- Green, Will
- Edwards, Mary
- Pont, Maria Angeles Lopez
- Gupta, Girish
- SpringerLink (Online service)
Other Objects (12)
Actinic keratosis metrics
Actinic keratosis : 4 tables
Diagnosis and therapy of actinic keratosis
Use of Lesion Response Rate in Actinic Keratosis Trials
Distant Resolution of Actinic Keratosis following Cryosurgery: An Unusual Phenomenon
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis
Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“: update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care
Cardiovascular Drug Use and Risk of Actinic Keratosis: A Case-Control Study
A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis
Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis
Actinic keratosis metrics
Actinic keratosis : 4 tables
Diagnosis and therapy of actinic keratosis
Use of Lesion Response Rate in Actinic Keratosis Trials
Distant Resolution of Actinic Keratosis following Cryosurgery: An Unusual Phenomenon
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis
Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“: update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care
Cardiovascular Drug Use and Risk of Actinic Keratosis: A Case-Control Study
A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis
Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis
Actinic keratosis metrics
Actinic keratosis : 4 tables
Diagnosis and therapy of actinic keratosis
Use of Lesion Response Rate in Actinic Keratosis Trials
Distant Resolution of Actinic Keratosis following Cryosurgery: An Unusual Phenomenon
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis
Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“: update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care
Cardiovascular Drug Use and Risk of Actinic Keratosis: A Case-Control Study
A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis